Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)
Hims & Hers Health's (HIMS) quarterly Non-Current Deffered Revenue came in at $384000.0 in Q1 2021, down 94.55% year-on-year from $7.0 million in Q1 2020, and up 0.79% quarter-over-quarter from $381000.0 in Q4 2020.
Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Hims & Hers Health has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $384000.0 for Q1 2021.
- Non-Current Deffered Revenue for Q1 2021 came in at $384000.0, down 94.55% year-over-year; the trailing twelve-month figure through Mar 2021 was $384000.0 (down 94.55% YoY), and the FY2020 annual result was $381000.0, down 94.59% from the prior year.
- Non-Current Deffered Revenue came in at $384000.0 for Q1 2021 at Hims & Hers Health, up from $381000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.0 million in Q3 2019 to a low of $381000.0 in Q4 2020.
- The 3-year median for Non-Current Deffered Revenue is $7.0 million (2019), against an average of $5.1 million.
- Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2020, while the deepest fall reached 94.59% in 2020.
- Hims & Hers Health's Non-Current Deffered Revenue stood at $7.0 million in 2019, then plunged by 94.59% to $381000.0 in 2020, then gained by 0.79% to $384000.0 in 2021.
- The last three Non-Current Deffered Revenue figures came in at $384000.0 (Q1 2021), $381000.0 (Q4 2020), and $7.0 million (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 384,000.00 |
| Dec 31, 2020 | 381,000.00 |
| Sep 30, 2020 | 7.04 Mn |
| Jun 30, 2020 | 7.04 Mn |
| Mar 31, 2020 | 7.04 Mn |
| Dec 31, 2019 | 7.04 Mn |
| Sep 30, 2019 | 7.04 Mn |